Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cosmos Health Inc (NQ: COSM ) 1.220 -0.060 (-4.69%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,118,113 Open 1.270 Bid (Size) 1.200 (50) Ask (Size) 1.230 (1) Prev. Close 1.280 Today's Range 1.201 - 1.360 52wk Range 0.4677 - 2.050 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements August 23, 2024 Via ACCESSWIRE Why Cosmos Health Stock Is Moving Higher Wednesday August 21, 2024 Cosmos Health announced that it continues to hold the right to distribute mpox real-time PCR detection kits under its agreement with Virax Biolabs Via Benzinga Performance YTD -10.95% -10.95% 1 Month +0.83% +0.83% 3 Month +74.54% +74.54% 6 Month +59.50% +59.50% 1 Year N/A N/A More News Read More Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE August 21, 2024 Via ACCESSWIRE Cosmos Health Holds EU Distribution Rights for Virax Biolabs’ Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits August 21, 2024 Via ACCESSWIRE COSM Stock Earnings: Cosmos Health Reported Results for Q2 2024 August 20, 2024 Via InvestorPlace Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE July 02, 2024 Via ACCESSWIRE Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023 August 20, 2024 Via ACCESSWIRE Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit August 20, 2024 Via ACCESSWIRE Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market August 08, 2024 Via ACCESSWIRE Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share August 06, 2024 Via ACCESSWIRE Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar July 25, 2024 Via ACCESSWIRE Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland July 25, 2024 Via ACCESSWIRE Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity July 24, 2024 Via ACCESSWIRE Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units July 18, 2024 Via ACCESSWIRE Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule July 18, 2024 Via ACCESSWIRE Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market July 10, 2024 Via ACCESSWIRE Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually July 09, 2024 Via ACCESSWIRE Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months July 02, 2024 Via ACCESSWIRE Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains July 01, 2024 Via ACCESSWIRE Why Cosmos Health Stock Is Trading Higher Friday June 28, 2024 Via Benzinga Why Is Elicio Therapeutics (ELTX) Stock Down 36% Today? June 28, 2024 Via InvestorPlace Why Is Nexalin Technology (NXL) Stock Down 35% Today? June 28, 2024 Via InvestorPlace Why Is Cosmos Health (COSM) Stock Up 65% Today? June 28, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 28, 2024 Via InvestorPlace Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units June 27, 2024 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.